About CPHI China 2025
ICE Pharma attended CPHI China 2025 which took place in Shanghai from 24th – 26th June.
CPHI China is Asia’s premier pharma event, bringing together suppliers and buyers from the entire pharmaceutical supply chain. Global pharma experts gather in Shanghai to network, source cost-effective solutions and conduct vital face-to-face business.
A big thank you to everyone who visited Booth E1C55, shared insights, and explored how ICE Pharma’s bile acid expertise and CDMO services can support your pharmaceutical goals.
We’re grateful for the meaningful conversations and collaborations.
Who We Are
ICE Pharma is a multinational company providing products and services to the pharmaceutical and healthcare markets
Founded more than 70 years ago, the Company has a network of manufacturing facilities and subsidiaries in North and South America, Europe, Asia and Oceania. We commercialise our products and services in all the major global markets and serve customers in over 50 countries.
We are a key supplier to the pharmaceutical industry providing a range of active pharmaceutical ingredients (APIs) including Ursodeoxycholic acid (UDCA) and Inosine Pranobex. We also supply excipients, cell culture media for diagnostics, GMP intermediates and research chemicals. Our services business provides contract manufacturing for solid and liquid finished dosage forms.
We manufacture and commercialise branded products in the pharmaceutical, nutraceutical and cosmetics markets.